Trial completion date • Trial primary completion date • CAR T-Cell Therapy • IO biomarker
|
CD20 (Membrane Spanning 4-Domains A1) • CD19 (CD19 Molecule) • CD22 (CD22 Molecule)
|
CD20 positive • CD19 expression
|
cyclophosphamide • fludarabine IV • Anti-CD19/CD20/CD22 CAR T-Cells